Institute of Rheumathology Prague

Prague 12850

0 studies enrolling now · 5 studies all time

What they study most

Lung Diseases, Interstitial, Lupus Nephritis, Scleroderma, Systemic

Studies at this site

• A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms — Completed
• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis — Completed
• An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis — Completed
• A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis — Completed